Skip to main content

Dri Healthcare Trust USD(DHT-U-T)
TSX

Today's Change
Real-Time Last Update
Day Low11.70
Day High11.71
Open:11.71
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024
DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 7, 2024
DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences
DRI Healthcare Trust to Host Fourth Quarter and Full Year 2023 Earnings Call and Webcast on February 29, 2024
DRI Healthcare Trust Declares Special Distributions
DRI Healthcare Trust Announces Upsized US$500 Million Credit Facilities
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 14, 2023
DRI Healthcare Trust Announces C$90 Million Bought Deal Public Offering of Units
DRI Healthcare Trust Announces C$85 Million Bought Deal Public Offering of Units

Profile

DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.